Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Total syntheses of macleanine and lycoposerramine-S

Masahiro Okuyama , Nariyoshi Umekubo , Kenta Akimoto , Takahisa Shimizu , Kazuhiro Kubokoya , Nagayasu Nakajima , Yoshitake Nishiyama and Satoshi Yokoshima *
Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya 464-8601, Japan. E-mail: yokosima@ps.nagoya-u.ac.jp

Received 4th July 2023 , Accepted 20th July 2023

First published on 21st July 2023


Abstract

Total syntheses of fawcettimine-class Lycopodium alkaloids having an imino bridge between C5 and C13 were accomplished. Fawcettimine was first prepared in 10 steps from a known compound, and the characteristic structures, including the imino bridge, were constructed via the formation of a bridgehead imine.


Hundreds of alkaloids have been isolated from Lycopodium species.1 These alkaloids can be classified into several groups on the basis of their core structure. Among these groups, the fawcettimine-class is a major group of Lycopodium alkaloids (Fig. 1).2 Fawcettimine has a cis-hydrindane core to which a nine-membered ring containing a nitrogen atom is fused. The nitrogen atom on the nine-membered ring forms a hemiaminal with a carbonyl function on the cis-hydrindane core, resulting in the formation of two heterocycles, a piperidine and an azepane. As minor constituents of the fawcettimine class, three alkaloids that have an imino bridge between C5 and C13 have been isolated.3 Although various total syntheses toward fawcettimine have been reported,4 synthetic efforts toward these alkaloids with the imino bridge are limited. Only two synthetic studies toward lycoposerramines-A and S[thin space (1/6-em)]5 and one total synthesis of lycoposerramine-S have been reported.6 However, no synthetic study on macleanine has thus far been reported. Herein we disclose our effort to synthesize fawcettimine-class alkaloids with an imino bridge between C5 and C13, resulting in the total syntheses of macleanine and lycoposerramine-S.
image file: d3ob01065a-f1.tif
Fig. 1 Structures of selected fawcettimine-class Lycopodium alkaloids.

We first planned the synthesis of macleanine, which has an aminal moiety in the structure. Aminals can be prepared via dehydrative condensation of a ketone or an aldehyde with two amines. This process involves the formation of an imine as an intermediate. In the synthesis of macleanine, the imine must be formed at a bridgehead position (Scheme 1a).7 Additional strain caused by the bicyclo[2.2.1] system appeared to introduce difficulties.8 To avoid the formation of strained bridgehead imines, we planned the synthetic route as shown in Scheme 1b. Thus, the sequential formation of C–N bonds via an intramolecular addition of a secondary amine moiety to an imine (I), followed by an intramolecular SN2 reaction (II), could construct the structure of macleanine without forming a bridgehead imine. The requisite substrate would be prepared from fawcettimine.


image file: d3ob01065a-s1.tif
Scheme 1 Synthetic plan toward macleanine.

We synthesized fawcettimine on the basis of our synthesis of huperzine Q,9 starting from the known enone 1 (Scheme 2).4p A Diels–Alder reaction of 1 with siloxydiene 2 produced the bicyclic compound 3, which was converted into enone 5via a three-step sequence involving the introduction of a phenylthio group, oxidation into a sulfoxide, and sulfoxide elimination under thermal conditions.10 After the sequential cleavage of the tert-butyloxycarbonyl (Boc) and tert-butyldiphenylsilyl (TBDPS) groups, a Mitsunobu reaction of the resultant hydroxy nosylamide formed a nine-membered ring,11 affording the tricyclic compound 7. Nucleophilic epoxidation with hydrogen peroxide under basic conditions afforded epoxyketone 8, which was subjected to ring contraction mediated by trimethylsilyl triflate (TMSOTf) as a Lewis acid to afford keto aldehyde 9.12,13 The nosyl and formyl groups were cleaved simultaneously by treatment with benzenethiol under basic conditions to yield fawcettimine.


image file: d3ob01065a-s2.tif
Scheme 2 Preparation of fawcettimine.

With a sufficient amount of fawcettimine in hand, we next attempted our planned synthesis of macleanine (Scheme 3).14 The Birch reduction of fawcettimine stereoselectively produced alcohol 10,9 and then the hemiaminal moiety was cleaved by a reaction with allyl chloroformate (AllocCl). The resultant ketone 11 was transformed into its oxime ether. Attempted mesylation of the secondary alcohol moiety in 12, to our surprise, produced methoxylamine 15. In this transformation, the mesylate formed in situ might be attacked by the oxime ether moiety to form the N-methoxyiminium ion 14, which was then trapped by water. Removal of the Alloc group with a palladium catalyst in dichloromethane and acetic acid afforded the pentacyclic aminal 16. Reductive cleavage of the N–O bond with zinc in aqueous acetic acid produced macleanine.


image file: d3ob01065a-s3.tif
Scheme 3 Transformation of fawcettimine into macleanine.

These results show that the aminal formation via an iminium ion proceeded more smoothly than expected,15 and led to more concise syntheses of the related alkaloids (Scheme 4). Thus, the conversion of fawcettimine into the corresponding oxime ether 17,16 followed by hydrogenation with platinum oxide (Adams catalyst) in acetic acid at room temperature, furnished macleanine in good yield.17 In addition, the reduction of oxime ether 17 with sodium cyanoborohydride in acetic acid, followed by reductive methylation, afforded tetracyclic amine 18, which could be converted into lycoposerramine-S via cleavage of the N–O bond.


image file: d3ob01065a-s4.tif
Scheme 4 Synthesis of fawcettimine-class alkaloids with an imino bridge.

In our synthesis, the additional bridge in the 2-azabicyclo[3.3.1] system might facilitate the formation of a bridgehead imine. Maier and Schleyer evaluated the stability of bridgehead double bonds using the olefinic strain energy (OS),18 which is related to the heat of hydrogenation of the olefins by a constant difference. According to their report, the OS of bicyclo[3.3.1]non-1-ene (19a) is 15.2 kcal mol−1, whereas that of olefin 19b, which has an additional ethylene bridge in the bicyclic system, is 12.5 kcal mol−1 (Table 1). These results indicate that the additional bridge lowers the strain. Unfortunately, the OS of olefin 19c has not been reported. However, density functional theory (DFT) calculations have shown that olefins 19b and 19c have approximately the same heats of hydrogenation: −38.6 kcal mol−1 and −38.4 kcal mol−1, respectively; thus, olefin 19c is also less strained than bicyclo[3.3.1]non-1-ene (19a). The heats of hydrogenation of the imines were also calculated, and comparing them revealed the same tendency; an additional bridge lowered the heat of hydrogenation, indicating that imine 20c is less strained than imine 20a.19

Table 1 Olefinic strain energies (OS) of bridgehead olefins and iminesa

image file: d3ob01065a-u1.tif

  19a 19b 19c 20a 20c
a All energies are in kcal mol−1. b Ref. 18a. The energies are calculated using Allinger's MM1 force field program. c B3PW91/6-311+G(d,p). d Not available. e Energy relative to the calculated heat of hydrogenation of olefin 19a. f Energy relative to the calculated heat of hydrogenation of imine 20a.
OSb 15.2 12.5 NAd
|ΔOS| 0 2.7 NAd
image file: d3ob01065a-t1.tif –41.6 –38.6 –38.4 –30.7 –26.3
image file: d3ob01065a-t2.tif 0 3.0e 3.2e 0 4.4f


In conclusion, we achieved total syntheses of the fawcettimine-class alkaloids macleanine and lycoposerramine-S via the formation of a bridgehead imine. We also showed that an additional bridge in the 2-azabicyclo[3.3.1] system could facilitate the formation of the bridgehead imine.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This work was financially supported by JSPS KAKENHI (Grant Number JP23H02602) and by the Research Support Project for Life Science and Drug Discovery [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from the Japan Agency for Medical Research and Development (AMED) under Grant Number JP23ama121044.

References

  1. (a) S. P. Patil, Future J. Pharm. Sci., 2020, 6, 99 CrossRef; (b) P. Siengalewicz, J. Mulzer and U. Rinner, in The Alkaloids: Chemistry and Biology, ed. H.-J. Knölker, Academic Press, 2013, vol. 72, pp. 1–151 Search PubMed; (c) J. i. Kobayashi and H. Morita, in The Alkaloids: Chemistry and Biology, ed. G. A. Cordell, Academic Press, 2005, vol. 61, pp. 1–57 Search PubMed; (d) X. Ma and D. R. Gang, Nat. Prod. Rep., 2004, 21, 752 RSC; (e) W. A. Ayer and L. S. Trifonov, in The Alkaloids; ed. G. A. Cordell, Academic Press, 1994, vol. 45, pp. 233–266 Search PubMed; (f) D. B. MacLean, in The Alkaloids; ed. A. Brossi, Academic Press, 1986, vol. 26, pp. 241–298 Search PubMed; (g) D. B. MacLean, in The Alkaloids; ed. R. H. F. Manske, Academic Press, 1973, vol. 14, pp. 348–405 Search PubMed; (h) D. B. MacLean, in The Alkaloids; ed. R. H. F. Manske, Academic Press, 1968, vol. 10, pp. 305–382 Search PubMed.
  2. (a) H. Li and X. Lei, Chem. Rec., 2018, 18, 543 CrossRef CAS PubMed; (b) R. A. Murphy and R. Sarpong, Chem. – Eur. J., 2014, 20, 42 CrossRef CAS PubMed; (c) X. Wang, H. Li and X. Lei, Synlett, 2013, 1032 CAS; (d) A. Nakayama, M. Kitajima and H. Takayama, Synlett, 2012, 2014 CAS.
  3. (a) W. A. Ayer, Y.-T. Ma, J.-S. Liu, M.-F. Huang, L. W. Schultz and J. Clardy, Can. J. Chem., 1994, 72, 128 CrossRef CAS; (b) H. Takayama, K. Katakawa, M. Kitajima, H. Seki, K. Yamaguchi and N. Aimi, Org. Lett., 2001, 3, 4165 CrossRef CAS PubMed; (c) H. Takayama, K. Katakawa, M. Kitajima, K. Yamaguchi and N. Aimi, Tetrahedron Lett., 2002, 43, 8307 CrossRef CAS.
  4. (a) T. Harayama, M. Takatani and Y. Inubushi, Tetrahedron Lett., 1979, 20, 4307 CrossRef; (b) T. Harayama, M. Takatani and Y. Inubushi, Chem. Pharm. Bull., 1980, 28, 2394 CrossRef CAS; (c) X. Linghu, J. J. Kennedy-Smith and F. D. Toste, Angew. Chem., Int. Ed., 2007, 46, 7671 CrossRef CAS PubMed; (d) K.-M. Liu, C.-M. Chau and C.-K. Sha, Chem. Commun., 2008, 91 RSC; (e) J. A. Kozak and G. R. Dake, Angew. Chem., Int. Ed., 2008, 47, 4221 CrossRef CAS PubMed; (f) Y. Otsuka, F. Inagaki and C. Mukai, J. Org. Chem., 2010, 75, 3420 CrossRef CAS PubMed; (g) M. E. Jung and J. J. Chang, Org. Lett., 2010, 12, 2962 CrossRef CAS PubMed; (h) J. Ramharter, H. Weinstabl and J. Mulzer, J. Am. Chem. Soc., 2010, 132, 14338 CrossRef CAS PubMed; (i) Y.-R. Yang, L. Shen, J.-Z. Huang, T. Xu and K. Wei, J. Org. Chem., 2011, 76, 3684 CrossRef CAS PubMed; (j) H. Li, X. Wang and X. Lei, Angew. Chem., Int. Ed., 2012, 51, 491 CrossRef CAS PubMed; (k) G. Pan and R. M. Williams, J. Org. Chem., 2012, 77, 4801 CrossRef CAS PubMed; (l) N. Itoh, T. Iwata, H. Sugihara, F. Inagaki and C. Mukai, Chem. – Eur. J., 2013, 19, 8665 CrossRef CAS PubMed; (m) S.-H. Hou, Y.-Q. Tu, L. Liu, F.-M. Zhang, S.-H. Wang and X.-M. Zhang, Angew. Chem., Int. Ed., 2013, 52, 11373 CrossRef CAS PubMed; (n) K. Xu, B. Cheng, Y. Li, T. Xu, C. Yu, J. Zhang, Z. Ma and H. Zhai, Org. Lett., 2014, 16, 196 CrossRef CAS PubMed; (o) C. Zeng, J. Zhao and G. Zhao, Tetrahedron, 2015, 71, 64 CrossRef CAS; (p) X. Zeng, Z. Jia and F. G. Qiu, Tetrahedron Lett., 2020, 61, 152329 CrossRef CAS.
  5. (a) M. C. Elliott, N. N. E. El Sayed and J. S. Paine, Org. Biomol. Chem., 2008, 6, 2611 RSC; (b) M. C. Elliott and J. S. Paine, Org. Biomol. Chem., 2009, 7, 3455 RSC.
  6. N. Shimada, Y. Abe, S. Yokoshima and T. Fukuyama, Angew. Chem., Int. Ed., 2012, 51, 11824 CrossRef CAS PubMed.
  7. (a) P. M. Warner, Chem. Rev., 1989, 89, 1067 CrossRef CAS; (b) J. Y. W. Mak, R. H. Pouwer and C. M. Williams, Angew. Chem., Int. Ed., 2014, 53, 13664 CrossRef CAS PubMed; (c) J. Liu, X. Liu, J. Wu and C.-C. Li, Chem, 2020, 6, 579 CrossRef CAS.
  8. D. W. Rogers, L. S. Choi, R. S. Girellini, T. J. Holmes and N. L. Allinger, J. Phys. Chem., 1980, 84, 1810 CrossRef CAS.
  9. S. Tanimura, S. Yokoshima and T. Fukuyama, Org. Lett., 2017, 19, 3684 CrossRef CAS PubMed.
  10. In the synthesis of huperzine Q, the corresponding transformation occurred through the oxidation of a silyl enolate with 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ).
  11. (a) T. Fukuyama, C.-K. Jow and M. Cheung, Tetrahedron Lett., 1995, 36, 6373 CrossRef CAS; (b) T. Kan, H. Kobayashi and T. Fukuyama, Synlett, 2002, 0697 CrossRef CAS; (c) T. Kan and T. Fukuyama, Chem. Commun., 2004, 353 RSC.
  12. Compounds 8 and 9 were obtained as single diastereomers.
  13. H. O. House and R. L. Wasson, J. Am. Chem. Soc., 1957, 79, 1488 CrossRef CAS.
  14. Results provided in Scheme 3 were investigated using racemic fawcettimine.
  15. (a) E. C. Taylor, J. E. Dowling and B. Bhatia, J. Org. Chem., 1999, 64, 441 CrossRef CAS; (b) N. Yamazaki, T. Kusanagi and C. Kibayashi, Tetrahedron Lett., 2004, 45, 6509 CrossRef CAS; (c) Y. Yoshimura, J. Inoue, N. Yamazaki, S. Aoyagi and C. Kibayashi, Tetrahedron Lett., 2006, 47, 3489 CrossRef CAS; (d) M. Amat, M. Pérez, A. T. Minaglia and J. Bosch, J. Org. Chem., 2008, 73, 6920 CrossRef CAS PubMed; (e) Y. Li, C. Feng, H. Shi and X. Xu, Org. Lett., 2016, 18, 324 CrossRef CAS PubMed; (f) X. Xie, B. Wei, G. Li and L. Zu, Org. Lett., 2017, 19, 5430 CrossRef CAS PubMed.
  16. K. Katakawa, M. Kitajima, N. Aimi, H. Seki, K. Yamaguchi, K. Furihata, T. Harayama and H. Takayama, J. Org. Chem., 2005, 70, 658 CrossRef CAS PubMed.
  17. The NMR data of TFA or HCl salt of synthetic macleanine matched the reported data.
  18. (a) W. F. Maier and P. V. R. Schleyer, J. Am. Chem. Soc., 1981, 103, 1891 CrossRef CAS; (b) M. Szostak and J. Aubé, Chem. Rev., 2013, 113, 5701 CrossRef CAS PubMed.
  19. The heat of hydrogenation of 1-azabicyclo[4.3.1]dec-10-ene (Scheme 1) was calculated as −37.1 kcal mol−1. This means that it is more strained than imine 20a.

Footnotes

Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3ob01065a
These authors contributed equally.

This journal is © The Royal Society of Chemistry 2023
Click here to see how this site uses Cookies. View our privacy policy here.